José Baselga

Member, Editorial Board at Annals of Oncology

José Baselga

José Baselga

Member, Editorial Board at Annals of Oncology

Overview
Career Highlights

European Society for Medical Oncology
Tango Therapeutics, Inc.
Mosaic Biomedicals SL

RelSci Relationships

6445

Number of Boards

3

Birthday

1959

Age

62

Number of Awards

1

Relationships
RelSci Relationships are individuals José Baselga likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Laura & Isaac Perlmutter Cancer Center

Relationship likelihood: Strong

Co-Founder at Mosaic Biomedicals SL

Relationship likelihood: Strong

Director at University of California - Berkeley

Relationship likelihood: Strong

Co-Founder at Mindstrong Health

Relationship likelihood: Strong

Co-Founder at PMV Pharmaceuticals, Inc.

Relationship likelihood: Strong

Group Leader at The Francis Crick Institute Ltd.

Relationship likelihood: Strong

Director-Cancer Center at The Massachusetts General Hospital

Relationship likelihood: Strong

President at City of Hope National Medical Center

Relationship likelihood: Strong

Scientific Founder at Blueprint Medicines Corp.

Relationship likelihood: Strong

Global Head, External Innovation at Johnson & Johnson Innovation LLC

Relationship likelihood: Strong

Paths to José Baselga
Potential Connections via
Relationship Science
You
José Baselga
Member, Editorial Board at Annals of Oncology
Education
PhD
Class of 1992

Autonomous University of Barcelona is a public university.

Memberships
Fellow
Current

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Member
Current

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Member
Current

American Society for Clinical Investigation is an American private company located in Ann Arbor, MI, that provides clinical investigation services.

Career History
Executive Vice President, Oncology R&D
2019 - Current

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Member, Editorial Board
Current
Professor of Medicine
Current

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

Boards & Committees
Member, Board of Directors
2017 - Current

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Member, Scientific Advisory Board
2016 - Current

Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.

Member, Scientific Advisory Board
Current

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in New Jersey, NY.

Member Emeritus, Board of Trustees
Current

ACCELERATES THE CONQUEST OF CANCER BY FUNDING SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION.

Board Member
Current

TO PROVIDE A CONTINUOUS EDUCATION PROGRAM FOR BOYS AND GIRLS FROM PRESCHOOL THROUGH HIGH SCHOOL.

President, Board of Directors
2008 - 2016

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $999
2015

The American-Italian Cancer Foundation provides cancer research, prevention, and early detection services. The company was founded in 1981 by Umberto Veronesi and is headquartered in New York, NY

$1 - $1,000
2009

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Investments
Details Hidden

Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, José Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.

Details Hidden

Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Queen Sofía Spanish Institute - Gold Medal
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by José Baselga. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of José Baselga's profile does not indicate a business or promotional relationship of any kind between RelSci and José Baselga.